Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling. (Q44615027)
scientific article published in October 2003
Language:
(P31) (Q13442814)
(P304) 4340-4346
(P407) (Q1860)
(P433) 12
(P478) 9
(P577) Wednesday, October 1, 2003
(P921) (Q61643320)
(Q128406)
(P1433) (Q332253)
(P1476) "Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling" (language: en)
(P2093) Qing-Bai She
David Solit
Andrea Basso
Mark M Moasser
other details
description scientific article published in October 2003

External Links